Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-16 Sale |
2022-11-17 6:21 pm |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
300 | $13.25 | $3,976 | 598,078 (Direct) |
View |
2022-11-10 Sale |
2022-11-14 6:43 pm |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
24,410 | $13.29 | $324,529 | 598,378 (Direct) |
View |
2022-09-14 Sale |
2022-09-16 7:07 pm |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
8,305 | $13.26 | $110,084 | 622,788 (Direct) |
View |
2022-09-09 Sale |
2022-09-13 4:07 pm |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
23,991 | $13.31 | $319,282 | 631,093 (Direct) |
View |
2022-09-07 Sale |
2022-09-09 4:00 pm |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $12.83 | $64,170 | 423,129 (Direct) |
View |
2022-06-15 Sale |
2022-06-17 4:08 pm |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $10.25 | $51,260 | 428,129 (Direct) |
View |
2021-12-09 Sale |
2021-12-13 6:06 pm |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
25,000 | $12.67 | $316,763 | 655,084 (Direct) |
View |
2021-11-19 Purchase |
2021-11-22 8:27 pm |
Akoya Biosciences Inc. | AKYA | Ramachandran Niro Ph.D Chief Business Officer |
25,073 | $13.13 | $329,231 | 25,073 (Direct) |
View |
2021-11-19 Purchase |
2021-11-19 12:55 pm |
Akoya Biosciences Inc. | AKYA | Mendel Scott Director |
8,500 | $13.16 | $111,860 | 8,500 (Direct) |
View |
2021-11-18 Purchase |
2021-11-18 9:08 pm |
Akoya Biosciences Inc. | AKYA | SHEPLER ROBERT G Director |
35,000 | $12.6 | $441,005 | 249,592 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-07 Exercise |
2022-09-09 4:00 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $0.303 | 423,129 (Direct) |
View |
2022-09-07 Exercise |
2022-09-09 4:00 pm |
N/A 2027-11-09 |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $0 | 423,129 (Direct) |
View |
2022-06-15 Exercise |
2022-06-17 4:08 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $0.303 | 428,129 (Direct) |
View |
2022-06-15 Exercise |
2022-06-17 4:08 pm |
N/A 2027-11-09 |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
5,000 | $0 | 428,129 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:08 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | SCHNETTLER THOMAS P Director |
30,549 | $0 | 2,844,320 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:07 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | Winkler Matthew Director |
30,549 | $0 | 811,674 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | LAI GOLDMAN MYLA Director |
30,549 | $0 | 30,549 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:04 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | SHEPLER ROBERT G Director |
30,549 | $0 | 280,141 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:04 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | Raffin Thomas A. Director |
30,549 | $0 | 15,910,388 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:03 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | Mendel Scott Director |
30,549 | $0 | 39,049 (Direct) |
View |
2022-06-01 Option Award |
2022-06-03 4:02 pm |
N/A 2032-06-01 |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
30,549 | $0 | 685,633 (Direct) |
View |
2022-05-19 Option Award |
2022-05-23 6:15 pm |
N/A 2032-05-19 |
Akoya Biosciences Inc. | AKYA | El-Gabry Ehab Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2022-04-19 12:18 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | El-Gabry Ehab Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
2022-04-13 Exercise |
2022-04-14 3:23 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | Ramachandran Niro Ph.D Chief Business Officer |
75,107 | $0.91 | 219,246 (Direct) |
View |
2022-04-13 Exercise |
2022-04-14 3:23 pm |
N/A 2030-03-23 |
Akoya Biosciences Inc. | AKYA | Ramachandran Niro Ph.D Chief Business Officer |
75,107 | $0 | 219,246 (Direct) |
View |
2022-03-23 Option Award |
2022-03-25 7:25 pm |
N/A 2032-03-23 |
Akoya Biosciences Inc. | AKYA | McKelligon Brian President/CEO |
240,000 | $0 | 240,000 (Direct) |
View |
2022-03-23 Option Award |
2022-03-25 7:24 pm |
N/A 2032-03-23 |
Akoya Biosciences Inc. | AKYA | Ramachandran Niro Ph.D Chief Business Officer |
67,500 | $0 | 92,573 (Direct) |
View |
2022-03-23 Option Award |
2022-03-25 7:23 pm |
N/A 2032-03-23 |
Akoya Biosciences Inc. | AKYA | DRISCOLL JOSEPH Chief Financial Officer |
37,500 | $0 | 37,500 (Direct) |
View |
2022-03-23 Option Award |
2022-03-25 7:22 pm |
N/A 2032-03-23 |
Akoya Biosciences Inc. | AKYA | Pla Frederic Chief Operating Officer |
67,500 | $0 | 67,500 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 6:23 pm |
N/A 2032-02-24 |
Akoya Biosciences Inc. | AKYA | Moy Marilee Chief People Officer |
120,000 | $0 | 120,000 (Direct) |
View |
Ownership |
2022-01-24 6:37 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | Moy Marilee Chief People Officer |
0 | $0 | 0 (Direct) |
View |
2021-09-16 Option Award |
2021-09-20 8:51 pm |
N/A 2031-09-16 |
Akoya Biosciences Inc. | AKYA | LAI GOLDMAN MYLA Director |
38,993 | $0 | 38,993 (Direct) |
View |
Ownership |
2021-09-20 8:48 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | LAI GOLDMAN MYLA Director |
0 | $0 | 0 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 9:59 pm |
N/A 2031-06-11 |
Akoya Biosciences Inc. | AKYA | Mendel Scott Director |
35,562 | $0 | 35,562 (Direct) |
View |
Ownership |
2021-06-15 9:58 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | Mendel Scott Director |
0 | $0 | 0 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 9:56 pm |
N/A 2031-05-21 |
Akoya Biosciences Inc. | AKYA | Winkler Matthew Director |
16,860 | $0 | 797,985 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 9:55 pm |
N/A 2031-05-21 |
Akoya Biosciences Inc. | AKYA | SCHNETTLER THOMAS P Director |
16,860 | $0 | 2,830,631 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 9:54 pm |
N/A 2031-05-21 |
Akoya Biosciences Inc. | AKYA | Raffin Thomas A. Director 10% Owner |
16,860 | $0 | 16,110,291 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 9:53 pm |
N/A 2031-05-21 |
Akoya Biosciences Inc. | AKYA | SHEPLER ROBERT G Director |
16,860 | $0 | 231,452 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 9:53 pm |
N/A 2031-05-21 |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
16,860 | $0 | 696,944 (Direct) |
View |
Ownership(A) |
2021-04-21 9:38 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director |
0 | $0 | 723,002 (Direct) |
View |
Ownership |
2021-04-20 7:52 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | SCHNETTLER THOMAS P Director |
0 | $0 | 2,813,771 (Direct) |
View |
Ownership |
2021-04-20 7:51 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | Raffin Thomas A. MACKOWSKI J MATTHEW Lashkari Deval Telegraph Hill Partners III L.P. THP III Affiliates Fund LLC Telegraph Hill Partners III Investment Management LLC Telegraph Hill Partners Management Company LLC Director 10% Owner |
0 | $0 | 16,104,431 (Direct) |
View |
Ownership |
2021-04-20 7:50 pm |
N/A N/A |
Akoya Biosciences Inc. | AKYA | SHEPLER ROBERT G Director |
0 | $0 | 214,592 (Direct) |
View |